Here are seven things to know:
1. The second quarter revenue increased 5.5 percent over the same period last year to $244.1 million.
2. The company reported net income for the second quarter at $26.3 million, or $0.79 per diluted share. This is up over the net income in the second quarter of 2014, at $22.2 million or $0.68 per diluted share.
3. The adjusted EBITDA for the second quarter was $50.5 million, or 20.7 percent of revenue. This exceeds the adjusted EBITDA from the same period last year, which reached $43.4 million or 18.8 percent of revenue.
4. Integra generated $18.1 million in cash flows from operations in the second quarter and invested $13.1 million in capital expenditures.
5. After the SeaSpine acquisition was complete July 1, the company updated its full-year 2015 guidance. The company now expects revenue to hit $870 million to $885 million.
6. Integra’s specialty surgical solutions revenue was up 7 percent to $146 million. Orthopedics and tissue technologies increased 10 percent to $63 million while spine revenue decreased 7 percent to $33.5 million.
7. The company also acquired TEI on July 17. “Our teams worked hard to complete the spin-off of SeaSpine ahead of schedule and close the strategic acquisition of TEI,” said Integra President and CEO Peter Arduini. “We are optimistic about the top-line growth acceleration and margin improvement these transactions will add to Integra.”
More articles on orthopedic devices:
5 key notes on NuVasive’s 10% share growth yesterday
SeaSpine Q1 revenue down 6% in first report as independent company
Smith & Nephew Q2 revenue up 5%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
